Array
(
[getDetailQuoteForCompanyReturn] => Array
(
[id] => 1212
[companyName] => ASTRA INDUSTRIAL
[companyNameAr] => أسترا الصناعية
[companyLongName] => Astra Industrial Group
[companyLongNameAr] => مجموعة أسترا الصناعية
[lastTradePrice] => 153
[lastTradeQuantity] => 3
[lastUpdateTime] => 2025-04-30 04:05:30
[open] => 155.2
[highPrice] => 157.6
[lowPrice] => 151.8
[prevClosePrice] => 153.8
[askPrice] => 153.8
[askQuantity] => 13
[bidPrice] => 153
[bidQuantity] => 1530
[noOfTrades] => 9948
[turnOver] => 45343072
[volumeTraded] => 293741
[avgTradeSize] => 29
[changeAmount] => -0.8
[changePercentage] => -0.52
[change52week] => -10.00
[high52weekDate] => 2025-01-08
[high52WeeksPrice] => 207
[low52weekDate] => 2025-04-07
[low52WeeksPrice] => 125.6
[startOfYearPrice] => 180.8
[yearAgoPrice] => 170
[threeyearAgoPrice] => 49.8
[bookValue] => 31.54
[closePrice] => 153.00
[earning] => 589.34
[EPS] => 7.37
[marketCap] => 12,240.00
[numberOfShares] => 80.000
[numberOfSharesFloated] => 39.016
[PBValue] => 4.84
[PERatio] => 20.76
[company_Announcents] => Array
(
[Announcement] => Array
(
[0] => Array
(
[announcement_Date] => 2025-04-29
[announcement_Time] => 2025-04-29 08:00:30
[description] => Astra Industrial Group announces its Interim Financial results for the Period Ending on 2025-03-31 ( Three Months )
[description_ar] => اعلان مجموعة أسترا الصناعية عن النتائج المالية الأولية للفترة المنتهية في 2025-03-31 ( ثلاثة أشهر )
[longDescription] =>

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	833,728,170	842,880,387	-1.085	721,601,089	15.538
Gross Profit (Loss)	372,598,003	350,539,320	6.292	330,344,397	12.79
Operational Profit (Loss)	189,301,115	168,460,082	12.371	161,828,003	16.976
Net profit (Loss)	171,871,096	149,741,384	14.778	131,438,601	30.761
Total Comprehensive Income	176,723,126	154,238,486	14.577	135,101,688	30.807
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Total Shareholders Equity (after Deducting Minority Equity)	2,700,529,204	2,282,141,098	18.333
Profit (Loss) per Share	2.15	1.87
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	–	–
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Sales decreases in general due to: Decrease in Sales in the following sectors: a) Steel industry b) Other (comparative period included sales from discontinued operation of Astra Mining)
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit Increases in general due to: 1. Increase in Gross Profit in Pharmaceuticals sector. 2. Decrease in finance costs in the following sector: A. Specialty chemical. B. Other.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Sales increases in general due to: Increase in Sales in the following sectors: a) Pharmaceuticals. b) Steel industry.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net profit Increases in general due to: 1. Increase Gross Profit in the Pharmaceuticals sector. 2. Decrease in finance costs in following sectors: A. Specialty chemical. B. Other.
Statement of the ty [longDescription_ar] => بند الربع الحالي الربع المماثل من العام السابق التغير% الربع السابق التغير % المبيعات/الايرادات 833,728,170 842,880,387 -1.085 721,601,089 15.538 اجمالي الربح (الخسارة) 372,598,003 350,539,320 6.292 330,344,397 12.79 الربح (الخسارة) التشغيلي 189,301,115 168,460,082 12.371 161,828,003 16.976 صافي الربح (الخسارة) 171,871,096 149,741,384 14.778 131,438,601 30.761 اجمالي الدخل الشامل 176,723,126 154,238,486 14.577 135,101,688 30.807 جميع الأرقام بالـ (حقيقي) ريال سعودي بند الفترة الحالية الفترة المماثلة من العام السابق التغير% إجمالي حقوق الملكية (بعد استبعاد الحصص غير المسيطرة) 2,700,529,204 2,282,141,098 18.333 ربحية (خسارة) السهم 2.15 1.87 جميع الأرقام بالـ (حقيقي) ريال سعودي بند القيمة النسبة من رأس المال مكاسب (خسائر) التغير في القيمة العادلة للعقارات الاستثمارية – – جميع الأرقام بالـ (حقيقي) ريال سعودي بند توضيح يعود سبب الارتفاع (الانخفاض) في المبيعات/ الإيرادات خلال الربع الحالي مقارنة بالربع المماثل من العام السابق يعود انخفاض الإيرادات بشكل عام انخفاض المبيعات في القطاعات التالية: أ‌) الصناعات الحديدية. ب‌) اخرى (تشمل الفترة المماثله للمبيعات من العمليات غير المستمرة لشركة أسترا للتعدين). يعود سبب الارتفاع ( الانخفاض ) في صافي الربح خلال الربع الحالي مقارنة مع الربع المماثل من العام السابق إلى يعود الارتفاع في صافي الربح بشكل عام إلى: 1. ارتفاع إجمالي الربح في قطاع الأدوية. 2. انخفاض تكاليف التمويل في القطاعات التالية: أ‌) المواد الكيميائية المتخصصة. ب‌) أخرى. يعود سبب الارتفاع (الانخفاض) في المبيعات/ الإيرادات خلال الربع الحالي مقارنة بالربع السابق يعود ارتفاع الإيرادات بشكل عام ارتفاع المبيعات في القطاعات التالية: أ‌) الأدوية. ب‌) الصناعات الحديدية. يعود سبب الارتفاع (الانخفاض) في صافي الربح خلال الربع الحالي مقارنة بالربع السابق يعودلارتفاع في صافي الربح بشكل رئيسي الى: 1. ارتفاع إجمالي الربح في قطاع الأدوية. 2. انخفاض تكاليف التمويل في القطاعات التالية: أ. المواد الكيميائية المتخصصة. ب. اخرى. بيان نوع تقرير مراجع الحسابات الرأي غير المعدل أي ملاحظة وردت في تقرير مراجع الحسابات متمثلة في فقرة أمر آخر أو تحفظ أو لفت انتباه أو امتناع عن إبداء الرأي أو رأي معارض كما ورد في تقرير مراجع الحسابات Element List Current Quarter Similar quarter for previous year %Change Previous Quarter % Change Sales/Revenue 833,728,170 842,880,387 -1.085 721,601,089 15.538 Gross Profit (Loss) 372,598,003 350,539,320 6.292 330,344,397 12.79 Operational Profit (Loss) 189,301,115 168,460,082 12.371 161,828,003 16.976 Net profit (Loss) 171,871,096 149,741,384 14.778 131,438,601 30.761 Total Comprehensive Income 176,723,126 154,238,486 14.577 135,101,688 30.807 All figures are in (Actual) Saudi Arabia, Riyals Element List Current Period Similar period for previous year %Change Total Shareholders Equity (after Deducting Minority Equity) 2,700,529,204 2,282,141,098 18.333 Profit (Loss) per Share 2.15 1.87 All figures are in (Actual) Saudi Arabia, Riyals Element List Amount Percentage of the capital (%) Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value – – All figures are in (Actual) Saudi Arabia, Riyals Element List Explanation The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is Sales decreases in general due to: Decrease in Sales in the following sectors: a) Steel industry b) Other (comparative period included sales from discontinued operation of Astra Mining) The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Net profit Increases in general due to: 1. Increase in Gross Profit in Pharmaceuticals sector. 2. Decrease in finance costs in the following sector: A. Specialty chemical. B. Other. The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is Sales increases in general due to: Increase in Sales in the following sectors: a) Pharmaceuticals. b) Steel industry. The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is Net profit Increases in general due to: 1. Increase Gross Profit in the Pharmaceuticals sector. 2. Decrease in finance costs in following sectors: A. Specialty chemical. B. Other. Statement of the ty [longDescription_ar] => بند الربع الحالي الربع المماثل من العام السابق التغير% الربع السابق التغير % المبيعات/الايرادات 833,728,170 842,880,387 -1.085 721,601,089 15.538 اجمالي الربح (الخسارة) 372,598,003 350,539,320 6.292 330,344,397 12.79 الربح (الخسارة) التشغيلي 189,301,115 168,460,082 12.371 161,828,003 16.976 صافي الربح (الخسارة) 171,871,096 149,741,384 14.778 131,438,601 30.761 اجمالي الدخل الشامل 176,723,126 154,238,486 14.577 135,101,688 30.807 جميع الأرقام بالـ (حقيقي) ريال سعودي بند الفترة الحالية الفترة المماثلة من العام السابق التغير% إجمالي حقوق الملكية (بعد استبعاد الحصص غير المسيطرة) 2,700,529,204 2,282,141,098 18.333 ربحية (خسارة) السهم 2.15 1.87 جميع الأرقام بالـ (حقيقي) ريال سعودي بند القيمة النسبة من رأس المال مكاسب (خسائر) التغير في القيمة العادلة للعقارات الاستثمارية – – جميع الأرقام بالـ (حقيقي) ريال سعودي بند توضيح يعود سبب الارتفاع (الانخفاض) في المبيعات/ الإيرادات خلال الربع الحالي مقارنة بالربع المماثل من العام السابق يعود انخفاض الإيرادات بشكل عام انخفاض المبيعات في القطاعات التالية: أ‌) الصناعات الحديدية. ب‌) اخرى (تشمل الفترة المماثله للمبيعات من العمليات غير المستمرة لشركة أسترا للتعدين). يعود سبب الارتفاع ( الانخفاض ) في صافي الربح خلال الربع الحالي مقارنة مع الربع المماثل من العام السابق إلى يعود الارتفاع في صافي الربح بشكل عام إلى: 1. ارتفاع إجمالي الربح في قطاع الأدوية. 2. انخفاض تكاليف التمويل في القطاعات التالية: أ‌) المواد الكيميائية المتخصصة. ب‌) أخرى. يعود سبب الارتفاع (الانخفاض) في المبيعات/ الإيرادات خلال الربع الحالي مقارنة بالربع السابق يعود ارتفاع الإيرادات بشكل عام ارتفاع المبيعات في القطاعات التالية: أ‌) الأدوية. ب‌) الصناعات الحديدية. يعود سبب الارتفاع (الانخفاض) في صافي الربح خلال الربع الحالي مقارنة بالربع السابق يعودلارتفاع في صافي الربح بشكل رئيسي الى: 1. ارتفاع إجمالي الربح في قطاع الأدوية. 2. انخفاض تكاليف التمويل في القطاعات التالية: أ. المواد الكيميائية المتخصصة. ب. اخرى. بيان نوع تقرير مراجع الحسابات الرأي غير المعدل أي ملاحظة وردت في تقرير مراجع الحسابات متمثلة في فقرة أمر آخر أو تحفظ أو لفت انتباه أو امتناع عن إبداء الرأي أو رأي معارض كما ورد في تقرير مراجع الحسابات Announcements Astra Industrial Group announces to Invites its Shareholders to Attend the ( First Meeting ) Ordinary General Assembly Meeting May 3, 2023 No Comments ent List Explanation Introduction The Board of Directors of Astra Industrial Group is pleased to invite the shareholders to participate and vote in the Extraordinary General Assembly (First Meeting) which will be held on Sunday 28/05/2023 corresponding 08/11/1444 H at 19:00PM via modern technology means using Tadawulaty System. City and Location of the General Assembly’s Meeting By means of modern technology – AIG Headquarter – Riyadh URL for the Meeting Location https://www.tadawulaty.com.sa Date of the General Assembly’s Meeting 2023-05-28 Corresponding to 1444-11-08 Time of the General Assembly’s Meeting 19:00 Attendance Eligibility Shareholders Registered in the Issuer’s Shareholders Registry in the Depository Centre At the End of the Trading Session Preceding the General Assembly’s Meeting as per Laws and Regulations Quorum for Convening the General Assembly’s Meeting The Meeting of the Ordinary General Assembly shall be valid only in the presence of shareholders representing half of the company’s capital. In the event that this quorum is not available in the first meeting, the second meeting will be held an hour after the end of the period specified for the first meeting, and the second meeting will be valid regardless of the number of shares represented therein. General Assembly Meeting Agenda Attached Proxy Form   E-Vote The shareholders who are registered in Tadawulaty Services can remotely vote on the Items of the Extraordinary General Assembly starting from 01:00 AM on Wednesday 24/05/2023G corresponding 04/11/1444 H and continue until the end of the Extraordinary General Assembly Meeting’s time, noting that registration and voting via Tadawulaty Services will be available and free of charge through the following link: www.tadawulaty.com.sa Eligibility for Attendance Registration and Voting Eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the Convenience of the General Assembly’s Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes Method of Communication For inquiries, please contact the Investors relations department on +966114752002 ext. 139, also you can direct your inquiries to the email of the investor relations department on: Khaled.albalawi@aig.sa Attached Documents   Attached Read More Astra Industrial Group announces its Annual Financial Results for the Period Ending on 2022-12-31 March 30, 2023 No Comments Element List Current Year Previous Year %Change Sales/Revenue 2,594,148,494 2,330,204,128 11.33 Gross Profit (Loss) 1,040,052,426 894,526,085 16.27 Operational Profit (Loss) 395,640,908 326,291,102 21.25 Net Profit (Loss) after Zakat and Tax 474,316,220 202,368,832 134.38 Total Comprehensive Income 517,745,586 185,794,439 178.66 Total Share Holders Equity (after Deducting Minority Equity) 1,849,376,401 1,451,641,002 27.4 Profit (Loss) per Share 5.93 2.53 All figures are in (Actual) Saudi Arabia, Riyals Element List Explanation The reason of the increase (decrease) in the net profit during the current year compared to the last year is Net profit increases in general due to:1. Gain from discontinued operation.2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticals.b) Specialty chemical.c) Steel industries.3. Decrease in foreign exchange and hyperinflation in the following sectors:a) Pharmaceuticals.b) Specialty chemical.4. Decrease in provision for impairment of financial assets in the following sectors:a) Specialty chemical.b) Steel industries.c) Other.While noting that there is increase in general and administrative expenses and selling and distribution expenses in all sectors. Statement of the type of external auditor’s report Unmodified opinion Reclassification of Comparison Items Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. Additional Information 1. Net Shareholders’ Equity at the end of the period was SR 1,913,185,390/- compared to SR 1,504,091,847 /- at the end of the similar period last year with an increase of 27%.2. With the completion of the sale of Al Anmaa during the period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 33 of the consolidated financial statements for further details. Read More Astra Industrial Group announces its Interim Financial Results for the Period Ending on 2022-09-30 ( Nine Months ) November 21, 2022 No Comments ELEMENT LIST CURRENT QUARTER SIMILAR QUARTER FOR PREVIOUS YEAR %CHANGE PREVIOUS QUARTER % CHANGE Sales/Revenue 622,067,121 611,990,489 1.65 608,544,428 2.22 Gross Profit (Loss) 219,942,168 243,176,125 -9.55 225,761,071 -2.58 Operational Profit (Loss) 76,510,835 71,849,086 6.49 91,400,602 -16.29 Net Profit (Loss) after Zakat and Tax 70,865,145 45,373,403 56.18 243,096,412 -70.85 Total Comprehensive Income 70,989,680 43,208,880 64.29 238,228,033 -70.2 All figures are in (Actual) Saudi Arabia, Riyals ELEMENT LIST CURRENT PERIOD SIMILAR PERIOD FOR PREVIOUS YEAR %CHANGE Sales/Revenue 1,865,130,534 1,739,623,541 7.21 Gross Profit (Loss) 719,580,291 706,557,987 1.84 Operational Profit (Loss) 263,217,470 260,075,244 1.21 Net Profit (Loss) after Zakat and Tax 388,651,783 150,579,006 158.1 Total Comprehensive Income 383,941,378 129,734,673 195.94 Total Share Holders Equity (after Deducting Minority Equity) 1,715,582,380 1,395,581,237 22.93 Profit (Loss) per Share 4.86 1.88 All figures are in (Actual) Saudi Arabia, Riyals ELEMENT LIST EXPLANATION The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Net profit increases in general due to:1. Decrease in selling and distribution expenses in the Pharmaceuticals sector2. Decrease in general and administrative expenses in the following sectors:a) Pharmaceuticalsb) Other3. Increase in other income in the following sectors:c) Pharmaceuticalsd) Other4. Decrease in loss from discontinued operationWhile noting that there is decrease in gross profit in the Pharmaceuticals sector. The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is Net profit decrease in general due to:1. Previous quarter included gain from discontinued operation2. Decrease in gross profit in the following sectors:a) Specialty chemicalb) PharmaceuticalsGross profit decrease was partially offset by increase in gross profit in power and steel sector.3. Increase in general and administrative expenses in the following sectors:a) Specialty chemicalb) Pharmaceuticals4. Increase in provision for impairment of financial assets expense in the following sectors:a) Pharmaceuticalsb) Power and steelWhile noting that there is increase in other income in Pharmaceuticals and Other sector. The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net profit increases in general due to:1. Gain from discontinued operation2. Decrease in other expenses in pharmaceuticals sector.3. Increase in sales and gross profit in the following sectors:a) Specialty chemicalb) Pharmaceuticals4. Decrease in provision for impairment of financial assets in all sectors.While noting that there is increase in selling and distribution expenses and general and administrative expenses in pharmaceuticals sector. Statement of the type of external auditor’s report Unmodified conclusion Reclassification of Comparison Items Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. Additional Information 1. Net Shareholders’ Equity at the end of the period was SR 1,714,921,175 /- compared to SR 1,448,185,342 /- at the end of the similar period last year with an increase of 18%.2. With the completion of the sale of Al Anmaa during the nine month period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details. Read More Astra Industrial Group announces its Interim Financial Results for the Period Ending on 2022-06-30 ( Six Months ) August 16, 2022 No Comments ELEMENT LIST CURRENT QUARTER SIMILAR QUARTER FOR PREVIOUS YEAR %CHANGE PREVIOUS QUARTER % CHANGE Sales/Revenue 608,544,428 533,087,193 14.15 634,518,985 -4.09 Gross Profit (Loss) 225,761,071 205,369,678 9.93 273,877,052 -17.57 Operational Profit (Loss) 91,400,602 71,019,085 28.7 95,306,033 -4.1 Net Profit (Loss) after Zakat and Tax 243,096,412 54,599,836 345.23 74,690,225 225.47 Total Comprehensive Income 238,228,033 48,500,974 391.18 74,723,664 218.81 All figures are in (Actual) Saudi Arabia, Riyals ELEMENT LIST CURRENT PERIOD SIMILAR PERIOD FOR PREVIOUS YEAR %CHANGE Sales/Revenue 1,243,063,413 1,127,633,052 10.24 Gross Profit (Loss) 499,638,123 463,381,862 7.82 Operational Profit (Loss) 186,706,635 188,226,158 -0.81 Net Profit (Loss) after Zakat and Tax 317,786,637 105,205,604 202.06 Total Comprehensive Income 312,951,697 86,525,793 261.69 Total Share Holders Equity (after Deducting Minority Equity) 1,644,592,701 1,352,372,354 21.61 Profit (Loss) per Share 3.97 1.32 All figures are in (Actual) Saudi Arabia, Riyals ELEMENT LIST EXPLANATION The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Net profit increases in general due to:1. Gain from discontinued operation2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemical The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is Net profit increases in general due to:1. Gain from discontinued operation2. Decrease in selling and distribution expenses in pharmaceuticals sector.3. Decrease in general and administrative expenses in the following sectors:a) Pharmaceuticalsb) Specialty chemicalc) OtherWhile noting that there is decrease in gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemicalc) Power and steel The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net profit increases in general due to:1. Gain from discontinued operation2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemical3. Decrease in other expenses in pharmaceuticals sector.4. Decrease in provision for impairment of financial assets in all sectors.While noting that there is increase in selling and distribution expenses and general and administrative expenses in all sectors. Statement of the type of external auditor’s report Unmodified conclusion Reclassification of Comparison Items Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. Additional Information 1. Net Shareholders’ Equity at the end of the period was SR1,644,232,915/- compared to SR1,407,057,157/- at the end of the similar period last year with an increase of 17%.2. With the completion of the sale of Al Anmaa during the period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details. Read More Previous 1 … 3 4 5 6 7 Next We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok